» Articles » PMID: 34387748

Complications Following MitraClip Implantation

Overview
Publisher Current Science
Date 2021 Aug 13
PMID 34387748
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: To provide a detailed overview of complications associated with MitraClip therapy and its development over time with the aim to alert physicians for early recognition of complications and to offer treatment strategies for each complication, if possible.

Recent Findings: The MitraClip system (MC) is the leading transcatheter technique to treat mitral regurgitation (MR) and has been established as a safe procedure with very low adverse event rates compared to mitral surgery at intermediate to high risk or in secondary MR. Lately, the fourth MC generation has been launched with novel technical features to facilitate device handling, decrease complication rates, and allow the treatment of even complex lesions. Although the complication rate is low, adverse events are associated with increased morbidity and mortality. The most common complications are bleeding, acute kidney failure, procedure-induced mitral stenosis, and an iatrogenic atrial septal defect with unknown clinical impact.

Citing Articles

Outcomes and Complications of Mitral and Tricuspid Transcatheter Edge-to-edge Repair.

Arnautovic J, YaQoub L, Wajid Z, Jacob C, Murlidhar M, Damlakhy A Interv Cardiol. 2024; 19:e20.

PMID: 39569385 PMC: 11577872. DOI: 10.15420/icr.2024.08.


Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System.

Euper M, Schreieck J, Bladt M, Zdanyte M, Goldschmied A, Sigle M Thromb Haemost. 2024; 125(2):130-141.

PMID: 39293482 PMC: 11785427. DOI: 10.1055/s-0044-1790604.


Acute type B aortic dissection following transcatheter mitral valve edge-to-edge repair: a case report.

Ma G, Zhou L, Cai D, Wang Y, Cai Z Eur Heart J Case Rep. 2024; 8(9):ytae424.

PMID: 39224439 PMC: 11368121. DOI: 10.1093/ehjcr/ytae424.


Mitral Transcatheter Edge-to-Edge Repair and Clinical Value of Novel Echocardiographic Biomarkers: A Hypothesis-Generating Study.

Solsona-Caravaca J, Fernandez-Galera R, Gonzalez-Fernandez V, Airale L, Rivas J, Scudeler L Biomedicines. 2024; 12(8).

PMID: 39200177 PMC: 11351940. DOI: 10.3390/biomedicines12081710.


Effectiveness of a new 3D printed simulator for mitral transcatheter edge-to-edge repair in enhancing the confidence and procedural skills of the operator.

Babu A, Bertolini M, Mullen M, Cook A, Mullen A, Capelli C 3D Print Med. 2024; 10(1):26.

PMID: 39102099 PMC: 11299365. DOI: 10.1186/s41205-024-00230-1.


References
1.
von Bardeleben R, Hobohm L, Kreidel F, Ostad M, Schulz E, Konstantinides S . Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants. EuroIntervention. 2019; 14(17):1725-1732. DOI: 10.4244/EIJ-D-18-00961. View

2.
Seeger J, Markovic S, Kessler M, Rottbauer W, Wohrle J . Apixaban After Percutaneous Edge-to-Edge Mitral Valve Repair in Patients With Maintained Sinus Rhythm. JACC Cardiovasc Interv. 2019; 12(2):214-216. DOI: 10.1016/j.jcin.2018.11.009. View

3.
Praz F, Braun D, Unterhuber M, Spirito A, Orban M, Brugger N . Edge-to-Edge Mitral Valve Repair With Extended Clip Arms: Early Experience From a Multicenter Observational Study. JACC Cardiovasc Interv. 2019; 12(14):1356-1365. DOI: 10.1016/j.jcin.2019.03.023. View

4.
Glower D, Kar S, Trento A, Lim D, Bajwa T, Quesada R . Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014; 64(2):172-81. DOI: 10.1016/j.jacc.2013.12.062. View

5.
Elbadawi A, Elgendy I, Mohamed A, Almahmoud M, Omer M, Abuzaid A . Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention. Cardiovasc Revasc Med. 2020; 21(12):1560-1566. DOI: 10.1016/j.carrev.2020.05.021. View